Phone
Address Talkabouturology, Nizhny Novgorod, Russia
Skype ukitcom
Email Talkabouturology@list.ru
                                    Talk about urology
Back to the list

Adding abiraterone to the current standard of care (SOC) prolonged radiographic progression-free survival (rPFS) compared with SOC alone in patients with metastatic castration-sensitive prostate cancer (mCSPC)

 https://www.renalandurologynews.com/home/news/urology/prostate-cancer/prostate-cancer-abiraterone-adt-docetaxel-treatment-risk/?utm_source=social&utm_medium=facebook&utm_content=f7629427-9083-4884-86e6-1ee1656215ca&utm_campaign=run_daily_posts